UBTD CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. UBTD Gen Silencer sind erhältlich als UBTD CRISPR/Cas9 Knockout Plasmide und UBTD Double Nickase Plasmide. UBTD CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
UBTD CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
UBTD1 CRISPR/Cas9 KO Plasmid (h) | sc-410145 | h | Gene Knockout | GFP | 0 | ||
UBTD1 HDR Plasmid (h) | sc-410145-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
UBTD1 Double Nickase Plasmid (h) | sc-410145-NIC | h | Gene Knockout | Puromycin | 0 | ||
UBTD1 Double Nickase Plasmid (h2) | sc-410145-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
UBTD1 CRISPR/Cas9 KO Plasmid (m) | sc-432595 | m | Gene Knockout | GFP | 0 | ||
UBTD1 HDR Plasmid (m) | sc-432595-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
UBTD1 Double Nickase Plasmid (m) | sc-432595-NIC | m | Gene Knockout | Puromycin | 0 | ||
UBTD1 Double Nickase Plasmid (m2) | sc-432595-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
UBTD2 CRISPR/Cas9 KO Plasmid (h) | sc-413929 | h | Gene Knockout | GFP | 0 | ||
UBTD2 HDR Plasmid (h) | sc-413929-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
UBTD2 Double Nickase Plasmid (h) | sc-413929-NIC | h | Gene Knockout | Puromycin | 0 | ||
UBTD2 Double Nickase Plasmid (h2) | sc-413929-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
UBTD2 CRISPR/Cas9 KO Plasmid (m) | sc-435868 | m | Gene Knockout | GFP | 0 | ||
UBTD2 HDR Plasmid (m) | sc-435868-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
UBTD2 Double Nickase Plasmid (m) | sc-435868-NIC | m | Gene Knockout | Puromycin | 0 | ||
UBTD2 Double Nickase Plasmid (m2) | sc-435868-NIC-2 | m | Gene Knockout | Puromycin | 0 |
UBTD CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
UBTD1 CRISPR Activation Plasmid (h) | sc-410145-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
UBTD1 CRISPR Activation Plasmid (h2) | sc-410145-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
UBTD1 Lentiviral Activation Particles (h) | sc-410145-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
UBTD1 Lentiviral Activation Particles (h2) | sc-410145-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
UBTD1 CRISPR Activation Plasmid (m) | sc-432595-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
UBTD1 CRISPR Activation Plasmid (m2) | sc-432595-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
UBTD1 Lentiviral Activation Particles (m) | sc-432595-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
UBTD1 Lentiviral Activation Particles (m2) | sc-432595-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
UBTD2 CRISPR Activation Plasmid (h) | sc-413929-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
UBTD2 CRISPR Activation Plasmid (h2) | sc-413929-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
UBTD2 Lentiviral Activation Particles (h) | sc-413929-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
UBTD2 Lentiviral Activation Particles (h2) | sc-413929-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
UBTD2 CRISPR Activation Plasmid (m) | sc-435868-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
UBTD2 CRISPR Activation Plasmid (m2) | sc-435868-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
UBTD2 Lentiviral Activation Particles (m) | sc-435868-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
UBTD2 Lentiviral Activation Particles (m2) | sc-435868-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |